While Illumina has outpaced current sequencing competitors on the market, namely Roche, Thermo Fisher (previously Life Technologies ), and Pacific Biosciences, venture capital continues to fund third-generation technologies that could eventually
entrants to the market in addition to competition from Life Technologies , Pacific Biosciences, and Oxford Nanopore, and ..... technologies exist from powerful players such as Life Technologies LIFE, Pacific Biosciences, and Oxford Nanopore
July 23 (Reuters) - Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, reported a higher-than-expected second-quarter profit in its first full quarterly results to include its acquisition of genetic testing company Life Technologies Corp.
remains growth through acquisitions, evidenced by its large purchases of Dionex and Phadia and pending acquisition of Life Technologies LIFE. We are somewhat wary of chronic acquirers, but Thermo Fisher has historically been disciplined with its approach
We are dropping coverage of Life Technologies as it has been successfully acquired by Thermo Fisher Scientific following regulatory approval and is no longer a publicly traded company.
Life Technologies reported third-quarter results on Tuesday that fell in line with our projections as strength in research consumables and applied
Life Technologies LIFE reported mixed second-quarter results on Wednesday that were highlighted by adequate earnings growth despite weak academic
TMO (rating: BBB, narrow moat) agreed to buy Life Technologies , we downgraded its rating from A+ previously ..... rating: BBB, narrow moat) has agreed to buy Life Technologies , which led to Thermo's recent downgrade. Thermo
paid off handsomely this year, with top 25 stock holdings like Biogen, Medtronic MDT, Johnson & Johnson JNJ, and Life Technologies LIFE all up more than 25% since the start of 2013. The fund has also benefitted from its overweight position in
Life Technologies LIFE posted better-than-expected first-quarter results on Thursday, despite academic funding weakness and global macroeconomic